The influence of tumour fluorodeoxyglucose avidity and cachexia development on patient survival in oesophageal or gastroesophageal junction cancer

Cancer cachexia is manifested by loss in muscle, adipose, weight, and appetite. PET 18F‐FDG uptake identifies tumour metabolic and inflammatory changes, potentially associated with cachexia development. We examined if primary gastroesophageal tumour 18F‐FDG uptake correlates with cachexia development and survival in cancer patients.

[1]  N. Mori,et al.  Prognostic role of low muscle mass and strength in palliative care patients with incurable cancer: a retrospective study , 2021, JCSM Clinical Reports.

[2]  P. Iyengar,et al.  Janus kinase inhibitors suppress cancer cachexia‐associated anorexia and adipose wasting in mice , 2020, JCSM rapid communications.

[3]  S. von Haehling,et al.  Cancer Cachexia and Related Metabolic Dysfunction , 2020, International journal of molecular sciences.

[4]  D. Kiel,et al.  Sarcopenia Definition: The Position Statements of the Sarcopenia Definition and Outcomes Consortium , 2020, Journal of the American Geriatrics Society.

[5]  P. Iyengar,et al.  Cachexia-associated adipose loss induced by tumor-secreted leukemia inhibitory factor is counterbalanced by decreased leptin. , 2018, JCI insight.

[6]  Yunfei Liu,et al.  The Warburg effect in human pancreatic cancer cells triggers cachexia in athymic mice carrying the cancer cells , 2018, BMC Cancer.

[7]  P. Iyengar,et al.  Impact of Socioeconomic Status on Pretreatment Weight Loss and Survival in Non-Small-Cell Lung Cancer. , 2018, Journal of oncology practice.

[8]  P. Iyengar,et al.  Prevalence and Survival Impact of Pretreatment Cancer-Associated Weight Loss: A Tool for Guiding Early Palliative Care. , 2018, Journal of oncology practice.

[9]  B. Shen,et al.  Revisit 18F-fluorodeoxyglucose oncology positron emission tomography: “systems molecular imaging” of glucose metabolism , 2017, Oncotarget.

[10]  J P Meyers,et al.  Cutpoint Determination Methods in Survival Analysis using SAS®: Updated %FINDCUT macro , 2015 .

[11]  Irfan M. Farukhi,et al.  Significance of 18F-Fluorodeoxyglucose Uptake at the Gastroesophageal Junction: Comparison of PET to Esophagogastroduodenoscopy , 2015, Digestive Diseases and Sciences.

[12]  M. Brock,et al.  Age and sex differences in the incidence of esophageal adenocarcinoma: results from the Surveillance, Epidemiology, and End Results (SEER) Registry (1973-2008). , 2014, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[13]  B. Krishnamachary,et al.  Metabolic signatures imaged in cancer-induced cachexia. , 2011, Cancer research.

[14]  Paula Ravasco,et al.  Definition and classification of cancer cachexia: an international consensus. , 2011, The Lancet. Oncology.

[15]  P. Ponikowski,et al.  Cachexia: a new definition. , 2008, Clinical nutrition.

[16]  M. Oudkerk,et al.  Decreased energy and phosphorylation status in the liver of lung cancer patients with weight loss. , 2000, Journal of hepatology.

[17]  John O'Quigley,et al.  An application of changepoint methods in studying the effect of age on survival in breast cancer , 1999 .

[18]  G. Marsh,et al.  Early Detection of Cancer Cachexia in the Rat Using 31P Magnetic Resonance Spectroscopy of the Liver and a Fructose Stress Test , 1996, NMR in biomedicine.

[19]  J. Gold.  CANCER CACHEXIA AND GLUCONEOGENESIS , 1974, Annals of the New York Academy of Sciences.